Analystreport

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) is now covered by analysts at Instinet. They set a "buy" rating and a $57.00 price target on the stock.

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations